+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction

Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction

Archives of Neurology 46(4): 464-468

Chloroquine induced a myasthenic syndrome in a patient taking the drug for presumable reticular erythematous mucinosis. Clinical features and results of single-fiber electromyography were typical for a failure of neuromuscular transmission, while peripheral nerves and muscles were intact on clinical, biochemical, electrophysiologic, and pathologic investigation. The time course of the clinical and electrophysiologic findings during provocation with chloroquine and the absence of autoantibodies indicate that the syndrome was due to a direct effect of the drug on the neuromuscular junction. While not taking chloroquine, the patient showed a decremental response on a modified double-step nerve stimulation test and a mean consecutive difference on single-fiber electromyography that was at the upper limit of normal, indicating a subclinical impairment of neuromuscular transmission. These findings can explain the apparent rarity of the syndrome described, as a direct effect of chloroquine on the neuromuscular junction may only have clinical relevance in patients with a reduced neuromuscular safety factor.

(PDF emailed within 0-6 h: $19.90)

Accession: 001891212

Download citation: RISBibTeXText

PMID: 2650665

DOI: 10.1001/archneur.1989.00520400124033

Related references

Histometric study of neuromuscular junction ultrastructure. II. Myasthenic syndrome. Neurology 22(4): 370-376, 1972

Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome. Neurology 76(3): 236-241, 2011

Ultrastructure of the thymus and neuromuscular junction in myasthenic and non-myasthenic patients. Morphologiai Es Igazsagugyi Orvosi Szemle 18(2): 107-116, 1978

Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Annals of the New York Academy of Sciences 183: 46-63, 1971

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome. Human Molecular Genetics 21(17): 3765-3775, 2012

Identification of neuromuscular junction acetylcholine receptor mutations in the slow-channel congenital myasthenic syndrome. Neurology 46(2 SUPPL ): A214, 1996

Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia. Current Treatment Options in Neurology 15(2): 224-239, 2012

Transplanting mutant human collagenic tailed acetylcholinesterase onto the frog neuromuscular junction Evidence for an attachment defect in a congenital myasthenic syndrome. Molecular Biology of the Cell 12(Supplement): 161a, 2001

Cross-linking of presynaptic calcium channels: A mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction. Neuroscience Letters 153(1): 45-48, 1993

Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy. Rinsho Shinkeigaku 39(5): 531-537, 1999

Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency. Faseb Journal 30(6): 2382-2399, 2016

The myasthenic neuromuscular junction. Lisak, R P Neurological Disease and Therapy; Handbook of myasthenia gravis and myasthenic syndromes 225-237, 1994

Morphology of the myasthenic neuromuscular junction. Annals of the New York Academy of Sciences 135(1): 35-59, 1966

Congenital myasthenic syndromes and the neuromuscular junction. Current Opinion in Neurology 27(5): 566-575, 2015